Systems Approaches to Cell Culture-Derived Extracellular Vesicles for Acute Kidney Injury Therapy: Prospects and Challenges
Function · 2024
DOI: 10.1093/function/zqae012 ↗At a glance
Übersichtsarbeit in Function, 2024. Written by David J Lundy and 2 co-authors. Institution: Graduate Institute of Biomedical Materials & Tissue Engineering, Taipei Medical University, Taipei 235603, Taiwan. Major MEDLINE topics: Acute Kidney Injury, Extracellular Vesicles. Cited 9 times so far (Crossref); 196 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Science and Technology, National Taiwan University Hospital.
Abstract (original language)
Acute kidney injury (AKI) is a heterogeneous syndrome, comprising diverse etiologies of kidney insults that result in high mortality and morbidity if not well managed. Although great efforts have been made to investigate underlying pathogenic mechanisms of AKI, there are limited therapeutic strategies available. Extracellular vesicles (EV) are membrane-bound vesicles secreted by various cell types, which can serve as cell-free therapy through transfer of bioactive molecules. In this review, we first overview the AKI syndrome and EV biology, with a particular focus on the technical aspects and therapeutic application of cell culture-derived EVs. Second, we illustrate how multi-omic approaches to EV miRNA, protein, and genomic cargo analysis can yield new insights into their mechanisms of action and address unresolved questions in the field. We then summarize major experimental evidence regarding the therapeutic potential of EVs in AKI, which we subdivide into stem cell and non-stem cell-derived EVs. Finally, we highlight the challenges and opportunities related to the clinical translation of animal studies into human patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Graduate Institute of Biomedical Materials & Tissue Engineering, Taipei Medical University, Taipei 235603, Taiwan.
- International PhD Program in Biomedical Engineering, Taipei Medical University, Taipei 235603, Taiwan.
- Center for Cell Therapy, Taipei Medical University Hospital, Taipei 110301, Taiwan.
- Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
- Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
- Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan.
ORCID profiles: David J Lundy, Barbara Szomolay, Chia-Te Liao
Funding
- Ministry of Science and Technology
- National Taiwan University Hospital
Cite
APA
Lundy, D. J., Szomolay, B., & Liao, C. T. (2024). Systems Approaches to Cell Culture-Derived Extracellular Vesicles for Acute Kidney Injury Therapy: Prospects and Challenges. Function. https://doi.org/10.1093/function/zqae012
Vancouver
Lundy DJ, Szomolay B, Liao CT. Systems Approaches to Cell Culture-Derived Extracellular Vesicles for Acute Kidney Injury Therapy: Prospects and Challenges. Function. 2024. doi:10.1093/function/zqae012
BibTeX
@article{Lundy2024,
author = {Lundy, David J and Szomolay, Barbara and Liao, Chia-Te},
title = {Systems Approaches to Cell Culture-Derived Extracellular Vesicles for Acute Kidney Injury Therapy: Prospects and Challenges},
journal = {Function},
year = {2024},
doi = {10.1093/function/zqae012}
}
EUVIMED